Mirati Therapeutics competitors

Mirati Therapeutics Competitors include OncoStem Diagnostics, Northwest Biotherapeutics, Merrimack Pharmaceuticals and TESARO.
Add company...
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs.
OncoStem Diagnostics
OncoStem Diagnostics
OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
TESARO
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
Founding Date
Founding Date
2013
Founding Date
2011
Founding Date
1998
Founding Date
2000
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Bengaluru, IN HQ
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
Waltham, US HQ
Employees
Employees
5134% increase
Employees
2011% increase
Employees
1440% increase
Employees
2763% decrease
Employees
446
Valuation ($)
Valuation ($)
2.6 b
Valuation ($)
N/A
Valuation ($)
234.2 m
Valuation ($)
89.3 m
Valuation ($)
4.1 b
Twitter followers
Twitter followers
101
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
$12.9m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$336k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$223.3m (FY, 2017)
Net income
Net income
($98.4m) (FY, 2018)
Net income
N/A
Net income
($73.1m) (FY, 2017)
Net income
($40.5m) (FY, 2018)
Net income
($496.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 7m
Total funding raised
$ 135.9m
Total funding raised
$ 79.4m
Total funding raised
$ 161m
For sources of this data, please see the company profileDownload Excel

View company profiles

OncoStem Diagnostics
HQ
Bengaluru, IN
Employees
20↑ 11% increase

OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.

View company
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
14↑ 40% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company